Education
About Us
Working with TipRanks
Follow Us
KALA BIO (KALA)
NASDAQ:KALA
Total Valuation
KALA BIO has a market cap or net worth of $5.28M. The enterprise value is $28.99M.
Market Cap$5.28M
Enterprise Value$28.99M
Share Statistics
KALA BIO has 7,021,040 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding7,021,040
Owned by Insiders10.52%
Owned by Institutions19.78%
Financial Efficiency
KALA BIO’s return on equity (ROE) is -3.12 and return on invested capital (ROIC) is -83.23%.
Return on Equity (ROE)-3.12
Return on Assets (ROA)-0.69
Return on Invested Capital (ROIC)-83.23%
Return on Capital Employed (ROCE)-1.06
Revenue Per Employee0.00
Profits Per Employee-1.01M
Employee Count38
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of KALA BIO is ―. KALA BIO’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.00
PB Ratio3.11
Price to Fair Value3.11
Price to FCF-1.29
Price to Operating Cash Flow-0.14
PEG Ratio0.02
Income Statement
In the last 12 months, KALA BIO had revenue of 0.00 and earned -38.51M in profits. Earnings per share was -6.98.
Revenue0.00
Gross Profit-259.00K
Operating Income-40.98M
Pretax Income-38.51M
Net Income-38.51M
EBITDA-40.98M
Earnings Per Share (EPS)-6.98
Cash Flow
In the last 12 months, operating cash flow was -32.03M and capital expenditures -53.00K, giving a free cash flow of -32.09M billion.
Operating Cash Flow-32.03M
Free Cash Flow-32.09M
Free Cash Flow per Share-4.57
Dividends & Yields
KALA BIO pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.85
52-Week Price Change-86.32%
50-Day Moving Average3.46
200-Day Moving Average5.72
Relative Strength Index (RSI)37.31
Average Volume (3m)1.94M
Important Dates
KALA BIO upcoming earnings date is Mar 26, 2026, After Close (Confirmed).
Last Earnings DateNov 17, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
KALA BIO as a current ratio of 3.11, with Debt / Equity ratio of -345.56%
Current Ratio3.11
Quick Ratio3.11
Debt to Market Cap0.79
Net Debt to EBITDA0.46
Interest Coverage Ratio-7.09
Taxes
In the past 12 months, KALA BIO has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
KALA BIO EV to EBITDA ratio is -0.47, with an EV/FCF ratio of -0.66.
EV to Sales0.00
EV to EBITDA-0.47
EV to Free Cash Flow-0.66
EV to Operating Cash Flow-0.66
Balance Sheet
KALA BIO has $21.10M in cash and marketable securities with $29.94M in debt, giving a net cash position of -$8.85M billion.
Cash & Marketable Securities$21.10M
Total Debt$29.94M
Net Cash-$8.85M
Net Cash Per Share-$1.26
Tangible Book Value Per Share$2.23
Margins
Gross margin is -3.15%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-3.15%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for KALA BIO is $1.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$1.50
Price Target Upside134.38% Upside
Analyst ConsensusHold
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast52.39%